NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.
NextGen Jane, a US-based developer of smart tampons based partly on Harvard University technology, has secured $9m in a series A round that included a group of angel investors from the university.
The consortium also included investors from Harvard-affiliated Massachusetts General Hospital, Harvard Medical School and Stanford University. The round was led by company builder Material Impact and included Access Industries, Viking Global Investors and Liminal Ventures.
Founded in 2014, NextGen Jane has developed a smart tampon that…
